ReP USP - Resultado da busca

Artigo de periodico
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells (2020)
Akula, Shaw M; Candido, Saverio; Abrams, Stephen L; Steelman, Linda S; Lertpiriyapong, Kvin; Cocco, Lucio; Ramazzotti, Giulia; Ratti, Stefano; Follo, Matilde Y; Martelli, Alberto M; Murata, Ramiro M; Rosalen, Pedro L; Bueno-Silva, Bruno; Alencar, Severino Matias de ; Falasca, Marco; Montalto, Giuseppe; Cervello, Melchiorre; Notarbartolo, Monica; Gizak, Agnieszka; Rakus, Dariusz; Libra, Massimo; McCubrey, James A
Source: Advances in Biological Regulation. Unidade: ESALQ
Subjects: ESTRADIOL, NEOPLASIAS PANCREÁTICAS, PRODUTOS NATURAIS, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKULA, Shaw M et al. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. Advances in Biological Regulation, v. 75, p. 1-15, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jbior.2019.100672. Acesso em: 16 nov. 2024.
APA
Akula, S. M., Candido, S., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., Cocco, L., et al. (2020). Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. Advances in Biological Regulation, 75, 1-15. doi:10.1016/j.jbior.2019.100672
NLM
Akula SM, Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Falasca M, Montalto G, Cervello M, Notarbartolo M, Gizak A, Rakus D, Libra M, McCubrey JA. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2020 ; 75 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jbior.2019.100672
Vancouver
Akula SM, Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Falasca M, Montalto G, Cervello M, Notarbartolo M, Gizak A, Rakus D, Libra M, McCubrey JA. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2020 ; 75 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jbior.2019.100672
Artigo de periodico
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals (2019)
Candido, Saverio; Abrams, Stephen L; Steelman, Linda S; Lertpiriyapong, Kvin; Martelli, Alberto M; Cocco, Lucio; Ratti, Stefano; Follo, Matilde Y; Murata, Ramiro M; Rosalen, Pedro L; Bueno-Silva, Bruno; Alencar, Severino Matias de ; Lombardi, Paolo; Mao, Weifeng; Montalto, Giuseppe; Cervello, Melchiorre; Rakus, Dariusz; Gizak, Agnieska; Lin, Heng-Liang; Libra, Massimo; Akula, Shaw M; McCubrey, James A
Source: Advances in Biological Regulation. Unidade: ESALQ
Subjects: NEOPLASIAS PANCREÁTICAS, QUIMIOTERAPIA, TERAPÊUTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANDIDO, Saverio et al. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals. Advances in Biological Regulation, v. 72, p. 22-40, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jbior.2019.03.002. Acesso em: 16 nov. 2024.
APA
Candido, S., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., Martelli, A. M., Cocco, L., et al. (2019). Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals. Advances in Biological Regulation, 72, 22-40. doi:10.1016/j.jbior.2019.03.002
NLM
Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Lombardi P, Mao W, Montalto G, Cervello M, Rakus D, Gizak A, Lin H-L, Libra M, Akula SM, McCubrey JA. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals [Internet]. Advances in Biological Regulation. 2019 ; 72 22-40.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jbior.2019.03.002
Vancouver
Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Lombardi P, Mao W, Montalto G, Cervello M, Rakus D, Gizak A, Lin H-L, Libra M, Akula SM, McCubrey JA. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals [Internet]. Advances in Biological Regulation. 2019 ; 72 22-40.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jbior.2019.03.002
Artigo de periodico
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells (2019)
Akula, Shaw M; Candido, Saverio; Libra, Massimo; Abrams, Stephen L; Steelman, Linda S; Lertpiriyapong, Kvin; Ramazzotti, Giulia; Ratti, Stefano; Follo, Matilde Y; Martelli, Alberto M; Murata, Ramiro M; Rosalen, Pedro L; Bueno-Silva, Bruno; Alencar, Severino Matias de; Montalto, Giuseppe; Cervello, Melchiorre; Gizak, Agnieszka; Rakus, Dariusz; Mao, Weifeng; Lin, Heng-Liang; Lombardi, Paolo; McCubrey, James A
Source: Advances in Biological Regulation. Unidade: ESALQ
Subjects: NEOPLASIAS PANCREÁTICAS, INIBIDORES DE ENZIMAS, TRANSDUÇÃO DE SINAL CELULAR, METFORMINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKULA, Shaw M et al. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. Advances in Biological Regulation, p. 1-19, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jbior.2019.04.003. Acesso em: 16 nov. 2024.
APA
Akula, S. M., Candido, S., Libra, M., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., et al. (2019). Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. Advances in Biological Regulation, 1-19. doi:10.1016/j.jbior.2019.04.003
NLM
Akula SM, Candido S, Libra M, Abrams SL, Steelman LS, Lertpiriyapong K, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lin H-L, Lombardi P, McCubrey JA. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2019 ; 1-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jbior.2019.04.003
Vancouver
Akula SM, Candido S, Libra M, Abrams SL, Steelman LS, Lertpiriyapong K, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Alencar SM de, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lin H-L, Lombardi P, McCubrey JA. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells [Internet]. Advances in Biological Regulation. 2019 ; 1-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jbior.2019.04.003

USP Schools

ReP

Filtros

Authors

Subjects

Non normalized affiliation

Countries of institutions of collaboration